Exact Sciences (EXAS) News Today $51.74 +1.30 (+2.58%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Artemis Investment Management LLP Boosts Stock Position in Exact Sciences Co. (NASDAQ:EXAS)Artemis Investment Management LLP increased its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 139.6% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 255,842 shares of the medical research company's stock after purJanuary 20 at 5:05 AM | marketbeat.comAvanza Fonder AB Takes Position in Exact Sciences Co. (NASDAQ:EXAS)Avanza Fonder AB purchased a new position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 19,512 shares of the medical research company'January 20 at 3:43 AM | marketbeat.comGateway Investment Advisers LLC Has $367,000 Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)Gateway Investment Advisers LLC trimmed its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 54.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,530 shares of the medical research company's stockJanuary 20 at 3:32 AM | marketbeat.comExact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?'January 18 at 9:15 PM | msn.com5,782 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Retirement Wealth Solutions LLCRetirement Wealth Solutions LLC purchased a new position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,782 shares of the medical research companyJanuary 18 at 7:31 AM | marketbeat.comBrookstone Capital Management Sells 5,077 Shares of Exact Sciences Co. (NASDAQ:EXAS)Brookstone Capital Management decreased its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 34.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,876 shares of the medical reseaJanuary 18 at 3:19 AM | marketbeat.comChannel Wealth LLC Sells 8,712 Shares of Exact Sciences Co. (NASDAQ:EXAS)Channel Wealth LLC decreased its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 23.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,274 shares of the medicalJanuary 17 at 8:17 AM | marketbeat.comExact Sciences Corporation (EXAS) Stock ForecastsJanuary 17 at 6:57 AM | ca.finance.yahoo.comWhy Exact Sciences (EXAS) Is Crashing?January 17 at 6:57 AM | msn.comExact Sciences (NASDAQ:EXAS) Stock Price Down 4.3% - What's Next?Exact Sciences (NASDAQ:EXAS) Shares Down 4.3% - Should You Sell?January 16, 2025 | marketbeat.comExact Sciences Stock Drops 12% Over Four Days. 'What Is Going On?'January 16, 2025 | msn.comBeech Hill Advisors Inc. Sells 11,383 Shares of Exact Sciences Co. (NASDAQ:EXAS)Beech Hill Advisors Inc. decreased its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 19.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 46,435 shares of the medical research company's stock after selling 11,383 shares durinJanuary 16, 2025 | marketbeat.com2 Healthcare Stocks to Buy Hand Over Fist in JanuaryJanuary 16, 2025 | fool.comExact Sciences: Strong Screening Revenue Growth and Strategic Initiatives Justify Buy RatingJanuary 15, 2025 | markets.businessinsider.comExact Sciences (NASDAQ:EXAS) Shares Gap Up - Should You Buy?Exact Sciences (NASDAQ:EXAS) Shares Gap Up - Still a Buy?January 15, 2025 | marketbeat.comWilliam Blair Reaffirms Outperform Rating for Exact Sciences (NASDAQ:EXAS)January 15, 2025 | americanbankingnews.comExact Sciences (NASDAQ:EXAS) Trading Down 4.3% - Here's WhyExact Sciences (NASDAQ:EXAS) Stock Price Down 4.3% - Here's WhyJanuary 14, 2025 | marketbeat.comBenchmark Reaffirms Buy Rating for Exact Sciences (NASDAQ:EXAS)January 14, 2025 | americanbankingnews.comWilliam Blair Reaffirms "Outperform" Rating for Exact Sciences (NASDAQ:EXAS)William Blair reaffirmed an "outperform" rating on shares of Exact Sciences in a report on Monday.January 13, 2025 | marketbeat.comCraig-Hallum Sticks to Their Buy Rating for Exact Sciences (EXAS)January 13, 2025 | markets.businessinsider.comExact Sciences’ Strong Q4 Performance and Growth Prospects Justify Buy RatingJanuary 13, 2025 | markets.businessinsider.comExact Sciences: Strong Q4 Results and Promising Pipeline Justify Buy RatingJanuary 13, 2025 | markets.businessinsider.comExact Sciences (NASDAQ:EXAS) Shares Gap Up - Still a Buy?Exact Sciences (NASDAQ:EXAS) Shares Gap Up - Here's WhyJanuary 13, 2025 | marketbeat.comExact Sciences (NASDAQ:EXAS) Given Buy Rating at BenchmarkBenchmark reaffirmed a "buy" rating and issued a $65.00 price objective on shares of Exact Sciences in a research note on Monday.January 13, 2025 | marketbeat.comExact Sciences reports preliminary Q4 revenue $713M, consensus $694.76MJanuary 13, 2025 | markets.businessinsider.comExact Sciences Announces Preliminary Fourth Quarter 2024 ResultsJanuary 12, 2025 | businesswire.comExact Sciences Co. (NASDAQ:EXAS) Shares Acquired by Harbor Capital Advisors Inc.Harbor Capital Advisors Inc. raised its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 35.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 95,827 shares of the medical research company's stock after aJanuary 11, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Receives $72.94 Consensus PT from AnalystsJanuary 11, 2025 | americanbankingnews.comBernstein Sticks to Its Buy Rating for Exact Sciences (EXAS)January 10, 2025 | markets.businessinsider.comLeerink Partnrs Predicts Higher Earnings for Exact SciencesJanuary 10, 2025 | americanbankingnews.comShould Exact Sciences Stock Stay in Your Portfolio Right Now?January 8, 2025 | msn.comExact Sciences Q2 EPS Forecast Increased by Leerink PartnrsExact Sciences Co. (NASDAQ:EXAS - Free Report) - Equities researchers at Leerink Partnrs increased their Q2 2025 earnings estimates for Exact Sciences in a research report issued on Tuesday, January 7th. Leerink Partnrs analyst P. Souda now expects that the medical research company will earn $0.0January 8, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesShares of Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eighteen research firms that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating and seventeen have given a buy rating to the company.January 8, 2025 | marketbeat.comExact Sciences price target raised to $70 from $60 at Evercore ISIJanuary 2, 2025 | markets.businessinsider.comExact Sciences to Participate in J.P. Morgan Healthcare ConferenceJanuary 2, 2025 | businesswire.comShort Interest in Exact Sciences Co. (NASDAQ:EXAS) Declines By 5.3%Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) was the target of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 11,200,000 shares, a drop of 5.3% from the November 30th total of 11,830,000 shares. Based on an average daily volume of 2,370,000 shares, the short-interest ratio is presently 4.7 days.January 1, 2025 | marketbeat.comPrincipal Financial Group Inc. Reduces Stock Position in Exact Sciences Co. (NASDAQ:EXAS)Principal Financial Group Inc. trimmed its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 19.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,049,256 shares of the medical research companDecember 22, 2024 | marketbeat.comTidal Investments LLC Acquires 21,683 Shares of Exact Sciences Co. (NASDAQ:EXAS)Tidal Investments LLC raised its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 172.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 34,275 shares of the medical research company's stock after buying an additional 21,683December 16, 2024 | marketbeat.comToronto Dominion Bank Sells 2,994,169 Shares of Exact Sciences Co. (NASDAQ:EXAS)Toronto Dominion Bank lowered its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 99.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 23,628 shares of the medical research company's stock after selDecember 16, 2024 | marketbeat.comPublic Employees Retirement System of Ohio Sells 8,728 Shares of Exact Sciences Co. (NASDAQ:EXAS)Public Employees Retirement System of Ohio trimmed its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 11.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 66,593 shares of the medical researDecember 15, 2024 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eighteen research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and sevenDecember 14, 2024 | marketbeat.comExact Sciences: Profitability Remains ElusiveDecember 13, 2024 | seekingalpha.comBank of America Cuts Exact Sciences (NASDAQ:EXAS) Price Target to $72.00Bank of America reduced their target price on shares of Exact Sciences from $75.00 to $72.00 and set a "buy" rating for the company in a report on Friday.December 13, 2024 | marketbeat.comExact Sciences (EXAS) Gets a Buy from TD CowenDecember 12, 2024 | markets.businessinsider.comGroupama Asset Managment Takes $821,000 Position in Exact Sciences Co. (NASDAQ:EXAS)Groupama Asset Managment bought a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,204,952 shares of the medical research company's stoDecember 10, 2024 | marketbeat.com30,579 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Zacks Investment ManagementZacks Investment Management bought a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 30,579 shares of the medical researchDecember 10, 2024 | marketbeat.comAAPA Awarded Grant from Exact Sciences to Improve Colorectal Cancer Screening RatesDecember 9, 2024 | globenewswire.comPier Capital LLC Makes New $5.52 Million Investment in Exact Sciences Co. (NASDAQ:EXAS)Pier Capital LLC purchased a new stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 81,036 shares of the medical research company's stock,December 8, 2024 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Stock Holdings Raised by Soros Fund Management LLCSoros Fund Management LLC boosted its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 68.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 378,590 shares of the medical research company's stDecember 6, 2024 | marketbeat.comPolar Asset Management Partners Inc. Acquires 45,800 Shares of Exact Sciences Co. (NASDAQ:EXAS)Polar Asset Management Partners Inc. raised its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 203.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 68,300 shares of the medical reseaDecember 5, 2024 | marketbeat.com Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address EXAS Media Mentions By Week EXAS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXAS News Sentiment▼0.750.44▲Average Medical News Sentiment EXAS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXAS Articles This Week▼209▲EXAS Articles Average Week Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Biogen News United Therapeutics News Neurocrine Biosciences News Incyte News BioMarin Pharmaceutical News Exelixis News Repligen News Halozyme Therapeutics News Madrigal Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXAS) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exact Sciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exact Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EXAS Stock Alerts